Brendan T Griffin (Brendan Griffin)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Machine Learning

Top Venues

Molecular pharmaceutics

The Journal of pharmacy and pharmacology

Drug development and industrial pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Justus Johann Lange, Andrea Anelli, Jochem Alsenz, Martin Kuentz, Patrick J O'Dwyer, Wiebke Saal, Nicole Wyttenbach, Brendan T Griffin
Comparative Analysis of Chemical Descriptors by Machine Learning Reveals Atomistic Insights into Solute-Lipid Interactions. Molecular pharmaceutics 21 (7) (2024)
Callum D Ryan, Brendan T Griffin, Joseph P O'Shea
Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax. Molecular pharmaceutics 21 (6) (2024)
Justus Johann Lange, Andrea Anelli, Jochem Alsenz, Martin Kuentz, Patrick J O'Dwyer, Wiebke Saal, Nicole Wyttenbach, Brendan T Griffin
Comparative Analysis of Chemical Descriptors by Machine Learning Reveals Atomistic Insights into Solute-Lipid Interactions. Molecular pharmaceutics (2024)
Callum D Ryan, Brendan T Griffin, Joseph P O'Shea
Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax. Molecular pharmaceutics 21 (6) (2024)
Callum D Ryan, Brendan T Griffin, Joseph P O'Shea
Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax. Molecular pharmaceutics (2024)
Justus Johann Lange, Andrea Anelli, Jochem Alsenz, Martin Kuentz, Patrick J O'Dwyer, Wiebke Saal, Nicole Wyttenbach, Brendan T Griffin
Comparative Analysis of Chemical Descriptors by Machine Learning Reveals Atomistic Insights into Solute-Lipid Interactions. Molecular pharmaceutics 21 (7) (2024)
Justus Johann Lange, Andrea Anelli, Jochem Alsenz, Martin Kuentz, Patrick J O'Dwyer, Wiebke Saal, Nicole Wyttenbach, Brendan T Griffin
Comparative Analysis of Chemical Descriptors by Machine Learning Reveals Atomistic Insights into Solute-Lipid Interactions. Molecular pharmaceutics 21 (7) (2024)
Mark McAllister, Talia Flanagan, Susan Cole, Andreas Abend, Evangelos Kotzagiorgis, Jobst Limberg, Heather Mead, Victor Mangas Sanjuan, Paul A Dickinson, Andrea Moir, Xavier Pepin, Diansong Zhou, Christophe Tistaert, Aristides Dokoumetzidis, Om Anand, Maxime Le Merdy, David B Turner, Brendan T Griffin, Adam Darwich, Jennifer Dressman, Claire Mackie
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series. Pharmaceutics 14 (5) (2022)
Sarah-Jane Leigh, Caoimhe M K Lynch, Brian R Healey Bird, Brendan T Griffin, John F Cryan, Gerard Clarke
Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects. Expert opinion on drug metabolism & toxicology 18 (1) (2022)
Joanne Heade, Fiona McCartney, Miguel Chenlo, Olga Moreno Marro, Maja Severic, Robert Kent, Sinead B Bleiel, Clara V Alvarez, Brendan T Griffin, David J Brayden
Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System. Pharmaceutics 13 (5) (2021)
Niklas J Koehl, Laura J Henze, Harriet Bennett-Lenane, Waleed Faisal, Daniel J Price, René Holm, Martin Kuentz, Brendan T Griffin
In Silico, In Vitro, and In Vivo Evaluation of Precipitation Inhibitors in Supersaturated Lipid-Based Formulations of Venetoclax. Molecular pharmaceutics 18 (6) (2021)
Harriet Bennett-Lenane, Joseph P O'Shea, Jack D Murray, Alexandra-Roxana Ilie, René Holm, Martin Kuentz, Brendan T Griffin
Artificial Neural Networks to Predict the Apparent Degree of Supersaturation in Supersaturated Lipid-Based Formulations: A Pilot Study. Pharmaceutics 13 (9) (2021)
Patrick J O'Dwyer, Karl J Box, Niklas J Koehl, Harriet Bennett-Lenane, Christos Reppas, Rene Holm, Martin Kuentz, Brendan T Griffin
Novel Biphasic Lipolysis Method To Predict in Vivo Performance of Lipid-Based Formulations. Molecular pharmaceutics 17 (9) (2020)
Alexandra-Roxana Ilie, Brendan T Griffin, Ruzica Kolakovic, Maria Vertzoni, Martin Kuentz, René Holm
Supersaturated lipid-based drug delivery systems - exploring impact of lipid composition type and drug properties on supersaturability and physical stability. Drug development and industrial pharmacy 46 (3) (2020)
Niklas J Koehl, Laura J Henze, Martin Kuentz, René Holm, Brendan T Griffin
Supersaturated Lipid-Based Formulations to Enhance the Oral Bioavailability of Venetoclax. Pharmaceutics 12 (6) (2020)
Niklas J Koehl, René Holm, Martin Kuentz, Vincent Jannin, Brendan T Griffin
Exploring the Impact of Surfactant Type and Digestion: Highly Digestible Surfactants Improve Oral Bioavailability of Nilotinib. Molecular pharmaceutics 17 (9) (2020)
Alexandra-Roxana Ilie, Brendan T Griffin, Maria Vertzoni, Martin Kuentz, Filip Cuyckens, Koen Wuyts, Ruzica Kolakovic, René Holm
Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients. Drug development and industrial pharmacy 46 (12) (2020)
Jacinta Walsh, Cassandra E Gheorghe, Joshua M Lyte, Marcel van de Wouw, Marcus Boehme, Timothy G Dinan, John F Cryan, Brendan T Griffin, Gerard Clarke, Niall P Hyland
Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin. The Journal of pharmacy and pharmacology 72 (8) (2020)
Brendan T Griffin, Jennifer B Dressman
The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines. The Journal of pharmacy and pharmacology 71 (4) (2019)
Laura J Henze, Niklas J Koehl, Joseph P O'Shea, Edmund S Kostewicz, René Holm, Brendan T Griffin
The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review. The Journal of pharmacy and pharmacology 71 (4) (2018)
Sandra Jankovic, Georgia Tsakiridou, Felix Ditzinger, Niklas J Koehl, Daniel J Price, Alexandra-Roxana Ilie, Lida Kalantzi, Kristof Kimpe, René Holm, Anita Nair, Brendan T Griffin, Christoph Saal, Martin Kuentz
Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL review. The Journal of pharmacy and pharmacology 71 (4) (2018)
Joseph P O'Shea, René Holm, Caitriona M O'Driscoll, Brendan T Griffin
Food for thought: formulating away the food effect - a PEARRL review. The Journal of pharmacy and pharmacology 71 (4) (2018)
Maria D Donovan, Khaled Abduljalil, John F Cryan, Geraldine B Boylan, Brendan T Griffin
Application of a physiologically-based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate. Biopharmaceutics & drug disposition 39 (3) (2018)
Felix Ditzinger, Daniel J Price, Alexandra-Roxana Ilie, Niklas J Köhl, Sandra Jankovic, Georgia Tsakiridou, Simone Aleandri, Lida Kalantzi, René Holm, Anita Nair, Christoph Saal, Brendan T Griffin, Martin Kuentz
Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL review. The Journal of pharmacy and pharmacology 71 (4) (2018)
Ken Howick, Shauna E Wallace-Fitzsimons, Dalia Kandil, Barbara Chruścicka, Mert Calis, Eoin Murphy, Brian A Murray, Ayoa Fernandez, Kate M Barry, Phil M Kelly, Aoife M Ryan, John F Cryan, Brendan T Griffin, Harriët Schellekens
A Dairy-Derived Ghrelinergic Hydrolysate Modulates Food Intake In Vivo. International journal of molecular sciences 19 (9) (2018)